SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $645 | -10.8% | 23,381 | -2.8% | 0.01% | -16.7% |
| Q2 2023 | $723 | -10.2% | 24,054 | +8.2% | 0.01% | -14.3% |
| Q1 2023 | $805 | -6.2% | 22,232 | -7.6% | 0.01% | -12.5% |
| Q4 2022 | $858 | -99.9% | 24,053 | +1.8% | 0.01% | 0.0% |
| Q3 2022 | $800,000 | +18.0% | 23,637 | +0.8% | 0.01% | +33.3% |
| Q2 2022 | $678,000 | -10.3% | 23,449 | +0.3% | 0.01% | 0.0% |
| Q1 2022 | $756,000 | -47.2% | 23,379 | -52.4% | 0.01% | +20.0% |
| Q4 2021 | $1,432,000 | +113.7% | 49,092 | +95.3% | 0.01% | -16.7% |
| Q3 2021 | $670,000 | -15.1% | 25,139 | -1.9% | 0.01% | 0.0% |
| Q2 2021 | $789,000 | +255.4% | 25,614 | +173.1% | 0.01% | +50.0% |
| Q4 2019 | $222,000 | -12.9% | 9,379 | +1.3% | 0.00% | -20.0% |
| Q3 2019 | $255,000 | -17.7% | 9,262 | -1.0% | 0.01% | -28.6% |
| Q2 2019 | $310,000 | +11.9% | 9,356 | +18.5% | 0.01% | 0.0% |
| Q1 2019 | $277,000 | +8.2% | 7,898 | +2.3% | 0.01% | 0.0% |
| Q4 2018 | $256,000 | -46.6% | 7,720 | -3.6% | 0.01% | -41.7% |
| Q2 2018 | $479,000 | +49.7% | 8,007 | +14.7% | 0.01% | +50.0% |
| Q1 2018 | $320,000 | +13.5% | 6,979 | -1.5% | 0.01% | 0.0% |
| Q4 2017 | $282,000 | +7.6% | 7,082 | +8.3% | 0.01% | 0.0% |
| Q3 2017 | $262,000 | -7.7% | 6,539 | -0.6% | 0.01% | -11.1% |
| Q2 2017 | $284,000 | – | 6,578 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
| MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
| Versant Capital Management, Inc | 16 | $463 | 0.00% |